Clinical Trials in Miami

Showing 41-60 of 8,701 trials

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

NCT05233397

ACTEMRA (tocilizumab) is an IL-6 receptor antagonist used for the treatment of adult Rheumatoid Arthritis as well as Polyarticular (PJIA) and Systemic (SJIA) Juvenile Idiopathic Arthritis. In this Phase II, the drug will be used to treat pediatric patients diagnosed with recurrent Adamantinomatous Craniopharyngioma including patients who have undergone surgery and/or radiation therapy.

Adamantinomatous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma

Nationwide Children's Hospital30 participantsStarted Dec 2022

Aurora, Colorado, United States • Washington D.C., District of Columbia, United States • Miami, Florida, United States +11 more locations

RECRUITINGPhase 3< 1 mile

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

NCT06563479

The researchers are doing this study to find out if a personalized approach to chemoradiation therapy (which may include a lower dose of radiation) is as effective as the standard chemoradiation therapy in people with HPV-positive throat cancer. Other purposes of this study include looking at the following: * Whether a lower dose of radiation in combination with standard chemotherapy causes fewer side effects than the standard dose of radiation therapy in combination with standard chemotherapy * How the study approaches (lower dose of radiation therapy + standard chemotherapy and standard dose of radiation therapy + standard chemotherapy) affect participants' quality of life. The researchers will measure quality of life by having participants fill out questionnaires.

HPV-Related Squamous Cell Carcinoma

Memorial Sloan Kettering Cancer Center291 participantsStarted Aug 2024

Hartford, Connecticut, United States • Miami, Florida, United States • Basking Ridge, New Jersey, United States +6 more locations

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

Find Trials by Condition in Miami

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

Evaluation of the Efficacy and Safety of LevoCept

A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Pyruvate Kinase Deficiency Global Longitudinal Registry

Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)